Scinai Immunotherapeutics Ltd.
SCNI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001611747
No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Scinai Immunotherapeutics Ltd. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 10 | 12 | +2 |
| Shares | 614.3K | 462.4K | −151.9K (−24.7%) |
| Value | $534.4K | $275.2K | −$259.2K (−48.5%) |
New holders (2)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Credit Agricole S A | 424 | $252 | 0.00% |
| Main Street Group, LTD | 200 | $119 | 0.00% |
Sold out (0)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q3 2023 and filed for Q4 2023 without it.
None.